Multiple-dose pharmacokinetic and pharmacodynamic interaction between ABT-335, rosuvastatin and warfarin.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2012
At a glance
- Drugs Choline fenofibrate; Rosuvastatin; Warfarin
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Abbott Laboratories
- 08 Oct 2010 Actual end date (July 2007) added as reported by ClinicalTrials.gov.
- 06 Dec 2007 Status changed from in progress to completed.
- 13 Jul 2007 New trial record.